Our data demonstrated that the FRAS1 levels were significantly elevated in primary tumors and liver metastatic nodes in CRC patients with liver metastasis, whereas no expression changes were observed between CRC primary tumors without liver metastasis and the matched controls (Fig. 4G). The gene discussed is FRAS1; the disease is colorectal carcinoma.